methyl 2-oxo-1-phenylpyrrolidine-3-carboxylate

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡咯烷类
• 英文名称: methyl 2-oxo-1-phenylpyrrolidine-3-carboxylate
• 化学式: C₁₂H₁₃NO₃
• 分子量: 219.24
• InChiKey: SXBVFIQUSXBDMR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  16
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  46.6
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  methyl 2-oxo-1-phenylpyrrolidine-3-carboxylate 在 potassium hydroxide 作用下， 以 甲醇 为溶剂， 生成 1-苯基-2-氧-3-吡咯烷羧酸
  参考文献：
  名称：

  Structure-Based Design of Novel Class II c-Met Inhibitors: 1. Identification of Pyrazolone-Based Derivatives

  摘要：

  Deregulation of c-Met receptor tyrosine kinase activity leads to tumorigenesis and metastasis in animal models. More importantly, the identification of activating mutations in c-Met, as well as MET gene amplification in human cancers, points to c-Met as an important target for cancer therapy. We have previously described two classes of c-Met kinase inhibitors (class I and class II) that differ in their binding modes and selectivity profiles. The class II inhibitors tend to have activities on multiple kinases. Knowledge of the binding mode of these molecules in the c-Met protein led to the design and evaluation of several new class II c-Met inhibitors that utilize various 5-membered cyclic carboxamides to conformationally restrain key pharmacophoric groups within the molecule. These investigations resulted in the identification of a potent and novel class of pyrazolone c-Met inhibitors with good in vivo activity.

  DOI：

  10.1021/jm201330u
• 作为产物：
  描述：

  苯胺 以 乙醇 、 二氯甲烷 为溶剂， 反应 0.08h， 生成 methyl 2-oxo-1-phenylpyrrolidine-3-carboxylate
  参考文献：
  名称：

  喹啉酮类化合物及其在药物中应用

  摘要：

  本发明涉及喹啉酮类化合物及其在药物中应用，还涉及包含所述化合物的药物组合物以及所述化合物或所述药物组合物在制备药物中的用途，所述药物用于防护、治疗或减轻患者HIF相关和/或EPO相关的疾病。

  公开号：

  CN108069952B

文献信息

• Bench‐Stable <i>S</i> ‐(Monofluoromethyl)sulfonium Salts: Highly Efficient <i>C</i> ‐ and <i>O</i> ‐Regioselective Monofluoromethylation of 1,3‐Dicarbonyl Compounds
  作者：Wen‐Bing Qin、Jian‐Jian Liu、Zhongyan Huang、Xin Li、Wei Xiong、Jia‐Yi Chen、Guo‐Kai Liu

  DOI：10.1002/ejoc.202000998

  日期：2020.9.30

  Novel bench‐stable S‐(monofluoromethyl)‐S‐phenyl‐S‐(2,4,6‐trialkoxyphenyl)sulfonium salts were readily prepared for C‐ and O‐regioselective monofluoromethylation of 1,3‐dicarbonyl compounds in good to excellent yields under mild reaction conditions.

  新型稳定的S-（单氟甲基）-S-苯基-S-（2,4,6-三烷氧基苯基）ulf盐易于制备，可用于1,3-二羰基化合物的C和O区域选择性单氟甲基化在温和的反应条件下。
• Synthesis of the Pentacyclic Skeleton of the Aspidosperma Alkaloids Using Rhodium Carbenoids as Reactive Intermediates
  作者：Albert Padwa、Alan T. Price

  DOI：10.1021/jo971424n

  日期：1998.2.1

  derivatives was treated with rhodium(II) acetate. Attack of the amido carbonyl oxygen at the resultant rhodium carbenoid center produced a transient push-pull carbonyl ylide dipole which underwent an intramolecular dipolar cycloaddition reaction. A related annulation sequence was used to prepare the pentacyclic skeleton of the aspidosperma family of alkaloids. Synthesis of the required diazo imide was

  用乙酸铑（II）处理由N-烯基取代的3-碳烷氧基-2-哌啶酮衍生物制得的一系列重氮酰胺基酮酯。酰胺基羰基氧在生成的铑类胡萝卜素中心的进攻产生了瞬时的推挽式羰基内酯偶极，该偶极经历了分子内偶极环加成反应。使用相关的环切序列来制备生物碱天冬子精子家族的五环骨架。由3-羧基-3-乙基-2-哌啶酮和N-甲基-3-吲哚乙酸合成所需的重氮酰亚胺。用乙酸铑（II）处理重氮酰亚胺，得到瞬态的1，3-偶极，其随后在吲哚π键上进行环加成。产生的环加合物是相对于偶极的内环加成的结果，其完全符合最低的能量跃迁状态。通过三个步骤将环加合物转化为脱乙酰氧基-4-氧代-6，7-二氢长春花碱。通过X射线晶体学研究确定最终产物的立体化学。
• Cardiac sarcomere inhibitors
  申请人：Cytokinetics, Inc.

  公开号：US11414424B2

  公开（公告）日：2022-08-16

  Provided are compounds of Formula (I): or a pharmaceutically acceptable salt thereof, wherein R1, R2A, R2B, R3, R4, and R5 are as defined herein. Also provided is a pharmaceutically acceptable composition comprising a compound of Formula (I), or a pharmaceutically acceptable salt thereof. Also provided are methods of using a compound of Formula (I), or a pharmaceutically acceptable salt thereof.

  提供的是式 (I) 化合物： 或其药学上可接受的盐，其中 R1、R2A、R2B、R3、R4 和 R5 如本文所定义。还提供了包含式（I）化合物或其药学上可接受的盐的药学上可接受的组合物。还提供了使用式（I）化合物或其药学上可接受的盐的方法。
• HOMOCONJUGATE ADDITION OF NUCLEOPHILES TO CYCLOPROPANE-1,1-DICARBOXYLATE DERIVATIVES: 2-OXO-1-PHENYL-3-PYRROLIDINECARBOXYLIC ACID
  作者：Singh, Rajendra K.、Danishefsky, Samuel

  DOI：10.15227/orgsyn.060.0066

  日期：——
• WO2020047447A5
  申请人：——

  公开号：WO2020047447A5

  公开（公告）日：2022-09-08